|
|
|
|
|
|
| Formulation And Process Challenges For A Needle-Shaped API | Case Study | By Alexander Schmid, Nadine Straede, and Jennifer Look, Rottendorf Pharma GmbH | Managing challenging active pharmaceutical ingredient crystal structures and choosing dry granulation over wet granulation requires strategic processing choices. |
|
|
|
|
|
By Louis Garguilo, Chief Editor, Outsourced Pharma | Heather Walters of CRB spends her time thinking about effective business and industrial sustainability and resource conservation. Meanwhile, Chief Editor Louis Garguilo maintains a position near the bottom of the list of interested parties. It made for great conversation. Uncovered were the current realities of sustainability in manufacturing facilities, and the importance of two components: electrification and digital twins. | |
|
|
Developing Your Vapor Phase Hydrogen Peroxide Cycle | By BioPhorum | Vapor phase hydrogen peroxide has been used for decades as a surface decontaminant in pharma/biotech, but there has been little guidance on how to establish the parameters. Here's an industry consensus from BioPhorum. |
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
| Overcoming Food Effects For A Non-Opioid Analgesic | Case Study | Catalent | Develop optimized lipid-based formulations to overcome solubility, stability, and food-effect challenges, enabling high-dose oral delivery and rapid progression to Phase 1 trials. |
|
|
| Don't Let Formulation Failures Derail Drug Development | White Paper | By Nazar Elkarim, Ph.D., Mikart | In the face of increasing molecular complexity, early developability assessment with a skilled CDMO can reduce pharmaceutical development costs, prevent clinical delays, and improve commercial success. |
|
|
|
| Work With An In-Country Depot For Efficiency And Compliance | Article | By Soudeh Tehrani, Lisa Lemelin, and Anh-Thu Le, Ropack Pharma Solutions | If you’re launching an international clinical trial, consider the noteworthy benefits of partnering with an in-country depot, including increased efficiency, reduced costs, and reliable access to raw materials. |
|
|
| Antibiotic Potency Testing By Microbial Assay | White Paper | By Alan Rédly, Ph.D., Eurofins | Selecting a potency assay for antibiotic drug substances and products carries regulatory, operational, and lifecycle implications that extend well beyond the laboratory. |
|
|
|
| Peptide Building Blocks: Navigating Quality, Supply, And Scale | E-Book | Grace Fine Chemical Manufacturing Services | Non-canonical amino acids can boost peptide half-life and potency, but create challenges in impurity control, GMP classification, and sourcing. Early supplier choices are critical for commercialization. |
|
|
|
|
| Enabling ADC Success | Dec. 1, 2026, 11:00 AM ET | This session explores the development, analytical, and manufacturing strategies supporting antibody-drug conjugate (ADC) and emerging conjugate programs. CDMOs will discuss challenges related to conjugation, CMC, developability, lyophilization, and complex payloads, including antibody-oligonucleotide conjugates. Attendees will gain insights into early risk mitigation, optimization strategies, and science-driven approaches that help improve program success and support efficient development and manufacturing. Learn more. |
|
|
|
|
|
|
|
|
|
OUTSOURCED PHARMA CAPABILITIES UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|